Analysts expect Kymera Therapeutics, Inc. to report revenue of 1.18 M for Q4 26, against a range of 1.14 M to 1.23 M. The most recent reported quarter, Q3 26, came in at 0.00, a 100.0% miss against the 3.09 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.39 M | 22.10 M | 11.48 M | 2.76 M | 2.87 M | 34.37 M | 65.00 M | 0.00 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 15.72 M | 10.77 M | 23.25 M | 23.66 M | 14.92 M | 8.15 M | 36.90 M | 3.25 M | 1.23 M | 7.52 M | 7.63 M | 8.94 M | -1.66 M | 15.82 M | 16.20 M | 7.20 M | |||||||||
| Low Estimate | 14.25 M | 9.97 M | 19.22 M | 21.94 M | 13.32 M | 7.50 M | 32.07 M | 2.94 M | 1.14 M | 6.48 M | 6.34 M | 7.92 M | -1.90 M | 14.43 M | 14.70 M | 6.29 M | |||||||||
| Consensus Estimate | 14.98 M | 10.37 M | 21.24 M | 22.80 M | 14.12 M | 7.83 M | 34.48 M | 3.09 M | 1.18 M | 7.00 M | 6.99 M | 8.43 M | -1.78 M | 15.13 M | 15.45 M | 6.74 M |
Analysts expect Kymera Therapeutics, Inc. to report earnings per share of -1.35 for Q4 26, against a range of -1.44 to -1.26. The most recent reported quarter, Q3 26, came in at -1.32, a 11.9% miss against the -1.18 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.88 | -0.82 | -0.95 | -0.94 | -0.97 | -0.71 | -0.62 | -1.32 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.73 | -0.82 | -0.81 | -0.70 | -0.74 | -0.89 | -0.69 | -1.08 | -1.26 | -1.15 | -1.34 | -1.23 | -1.31 | -1.17 | -1.32 | -1.42 | |||||||||
| Low Estimate | -0.87 | -0.88 | -0.93 | -0.80 | -0.90 | -0.95 | -0.77 | -1.28 | -1.44 | -1.39 | -1.60 | -1.47 | -1.59 | -1.31 | -1.44 | -1.68 | |||||||||
| Consensus Estimate | -0.80 | -0.85 | -0.87 | -0.75 | -0.82 | -0.92 | -0.73 | -1.18 | -1.35 | -1.27 | -1.47 | -1.35 | -1.45 | -1.24 | -1.38 | -1.55 |
Pull Wall Street consensus for Kymera Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=KYMR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "KYMR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=KYMR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();